Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2022
Ascletis expands ritonavir tablet production capacity
Ascletis expanded the annual production capacity of its ritonavir oral tablets to 100 million tablets, with the possibility of further increases based on market demand.